Acute graft versus host disease (GVHD) remains a major cause of morbidity and mortality in allogeneic bone marrow transplantation. In the previous grant period we demonstrated an association between polymorphisms in a DQ- beta gene (hereafter referred to as the DQR gene) and the risk of developing GVHD following allogeneic BMT. These results suggested the existence of DNA sequences homologous to but not identical with DQ-beta, that may encode an antigen or antigens responsible for GVHD. The data also suggest that the locus or loci detected by the DNA probe and highly polymorphic and unlinked to HLA. These results provides an incentive to clone and further characterize the DQR gene. Our collaborator, Dr. Georgia Vogelsang has developed a skin-explant model for GVHD using donor lymphocytes that have been sensitized against recipient lymphocytes in vitro and co-cultured with the recipient's skin. Histologic changes compatible with GVHD are found in the positive explants. We plan to combine molecular genetic techniques and the skin explant model in order to test our hypothesis that the DQR gene encodes the minor histocompatibility antigen(s) responsible for the allo-reaction of the donor immune system against the recipient (GVHD). We are proposing a project with three main goals: (1) to clone and characterize the DQR gene; including isolating candidate clones, determining their DNA sequence, deducing the structure of a putative protein product of the gene(s) and determining whether the gene is a single or multiple gene system. (2) to evaluate polymorphisms in the gene; including characterizing polymorphisms associated with the gene (RFLPs), determining if the putative protein product is polymorphic (amino acid sequence variation), re-evaluating the relationship between genetic differences between donors and recipients (RFLPs) and the risk of developing acute GVHD and determining whether genetic non-identity between donors and recipients correlates with positive reactions in a skin explant model system. (3) to study the expression of the gene; including determining whether the gene is expressed and where the gene is expressed and where and determining whether or not the gene is expressed in cultured skin fibroblasts used in the skin explant model for GVHD and if so then clone the cDNA and determine its structure.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA030206-12
Application #
3772242
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1993
Total Cost
Indirect Cost
Name
City of Hope National Medical Center
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Limaye, Ajit P; La Rosa, Corinna; Longmate, Jeff et al. (2016) Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients. Transplantation 100:210-6
Jonnalagadda, Mahesh; Mardiros, Armen; Urak, Ryan et al. (2015) Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther 23:757-68
Wang, Xiuli; Wong, ChingLam W; Urak, Ryan et al. (2015) CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells. Clin Cancer Res 21:2993-3002
Mardiros, Armen; Forman, Stephen J; Budde, Lihua E (2015) T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia. Curr Opin Hematol 22:484-8
Caruso, Hillary G; Hurton, Lenka V; Najjar, Amer et al. (2015) Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity. Cancer Res 75:3505-18
Israyelyan, A; Goldstein, L; Tsai, W et al. (2015) Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation. Bone Marrow Transplant 50:26-33
Wussow, Felix; Chiuppesi, Flavia; Martinez, Joy et al. (2014) Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. PLoS Pathog 10:e1004524
Rushworth, David; Jena, Bipulendu; Olivares, Simon et al. (2014) Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificity. J Immunother 37:204-13
Jena, Bipulendu; Moyes, Judy S; Huls, Helen et al. (2014) Driving CAR-based T-cell therapy to success. Curr Hematol Malig Rep 9:50-6
Singh, Harjeet; Huls, Helen; Kebriaei, Partow et al. (2014) A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19. Immunol Rev 257:181-90

Showing the most recent 10 out of 364 publications